tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR

Compare Monopar Therapeutics Inc (MNPR) vs. Competitors

Compare
569 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monopar Therapeutics Inc
$55.21
$375.96M
-42.31
40.65%
7 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$1.80
$121.69M
-4.09
-52.53%
6 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$7.00
$413.76M
-2.36
46.75%
4 Buy
1 Hold
0 Sell
Strong Buy
Verastem
$5.39
$473.43M
-2.55
-18.95%
6 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$0.34
$54.42M
-85.63%
5 Buy
3 Hold
0 Sell
Moderate Buy
Silence Therapeutics
$6.17
$272.78M
-3.24
62.22%
4 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNPR
Monopar Therapeutics Inc
56.26
18.66
49.63%
CRDF
Cardiff Oncology
1.78
-2.01
-53.03%
VNDA
Vanda
7.00
2.18
45.23%
VSTM
Verastem
5.39
-1.49
-21.66%
MREO
Mereo Biopharma Group Plc
0.34
-2.15
-86.27%
SLN
Silence Therapeutics
5.78
2.29
65.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts